Ascendis Pharma Q4 EPS $(0.64) Misses $(0.06) Estimate, Sales $288.127M Miss $289.720M Estimate
Ascendis Pharma (NASDAQ:ASND) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.06) by 966.67 percent. This is a 5.88 percent increase over losses of $(0.68) per share from
